REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus Oncology, Inc. (CHRS) on Thursday reported net income of $297.8 million in its second quarter.
The Redwood City, California-based company said it had net income of $2.57 per share. Losses, adjusted for one-time gains and costs, came to 34 cents per share.
The drug developer posted revenue of $10.3 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
